Showing 3961-3970 of 10624 results for "".
Topline Results of the CONFIDENCE Trial
https://reachmd.com/cme/ACC-2025-nsMRA-HF/topline-results-of-the-confidence-trial/35767/Dr. Rajiv Agarwal presents CONFIDENCE topline results: finerenone + empagliflozin lowers albuminuria, showing promise in CKD and T2D care.Investigator Perspectives on Treating Patients in a Ph2 NSCLC Trial
https://reachmd.com/programs/project-oncology/investigator-perspectives-on-treating-patients-in-a-ph2-nsclc-trial/26564/High c-MET protein overexpression is a MET aberration2,3 seen in about 1 in 7 or 14% of patients with EGFR wild-type non-squamous non-small cell lung cancer (NSCLC) tumors. Telisotuzumab vedotin-tllv (Teliso-V) is a first-in-class, c-Met protein-directed antibody-drug conjugate that was studied in tPancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
https://reachmd.com/programs/project-oncology/pancreatic-cancer-associated-signs-symptoms-and-risk-factors-and-treatment-approaches/9552/Though Pancreatic Cancer is the 9th most common cancer, overall, it’s the number 4 cause of cancer deaths.What Lies Beneath the Simple Ankle Sprain
https://reachmd.com/programs/clinicians-roundtable/what-lies-beneath-the-simple-ankle-sprain/3527/Commonly perceived as a minor injury, ankle sprains are dismissed by many athletes, in particular, who are encouraged to shake it off, play through pain, and pursue some simple rehab as their game and practice schedule allows. Yet there is more to simple ankle sprains than we may realize, includingJAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
https://reachmd.com/programs/living-rheum/jak-inhibitors-psoriatic-arthritis-safety-real-world/56344/Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
https://reachmd.com/programs/neurofrontiers/spinal-muscular-atrophy-reveals-hidden-kidney-impairment-risk/54641/Comorbidities in Psoriasis
https://reachmd.com/topics/psoriasis/comorbidities-in-psoriasis/54453/Psoriasis is associated with numerous systemic comorbidities, many of which are linked through IL-17/IL-23-mediated inflammation. Comorbid conditions such as diabetes, IBD, metabolic syndrome, and PsA are not only more prevalent but often more severe in psoriasis patients, highlighting the importanBiological and Environmental Factors in Facial Eczema
https://reachmd.com/topics/atopic-dermatitis/biological-and-environmental-factors-in-facial-eczema/54270/Roflumilast Foam for Psoriasis: Efficacy, Tolerability, and Clinical Relevance
https://reachmd.com/programs/dermconsult/roflumilast-foam-for-psoriasis-efficacy-tolerability-and-clinical-relevance/36370/Early Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
https://reachmd.com/programs/heart-matters/early-initiation-of-acoramidis-in-attr-cm-importance-and-long-term-impacts/35757/Acoramidis, a treatment for transthyretin amyloid cardiomyopathy (ATTR-CM), was studied in an open-label extension of the ATTRibute-CM trial to determine whether its early and sustained use improves clinical outcomes. Discover acoramidis’ long-term impacts on all-cause mortality and/or first cardiov